Search results for "Multidrug-Resistant"

showing 10 items of 23 documents

Antiproliferative activity against leukemia cells of sesquiterpene lactones from the Turkish endemic plant Centaurea drabifolia subsp. detonsa

2017

The apolar organic extract obtained from aerial parts of Centaurea drabifolia Sibth. & Sm. subsp. detonsa (Bornm.) Wagenitz, growing wild in Turkey, was investigated for the first time for its secondary metabolite composition. Seven sesquiterpene lactones belonging to the guaiane class (1-7), including the new compound 4, along with a fatty acid lactone derivative (8), were isolated. The structures of these compounds were established by spectroscopic analysis, including 2D NMR spectroscopic techniques, with the stereostructure of the new guaiane 4 determined with the help of MTPA derivatization. Cytotoxic activities of compounds 1-7 were evaluated against two cancer cell lines, namely acute…

TurkeyCentaurea drabifoliaStereochemistryCynaropicrinCentaureaMultidrug-resistant cell lineSecondary metaboliteBiologySesquiterpene01 natural sciencesLactonesSesquiterpenes GuaianeStructure-Activity Relationshipchemistry.chemical_compoundCell Line TumorDrug DiscoverymedicineHumansDerivatizationPharmacologychemistry.chemical_classificationLeukemiaMolecular StructurePlant Extracts010405 organic chemistryFatty acidGeneral MedicinePlant Components AerialAntineoplastic Agents PhytogenicCynaropicrin0104 chemical sciences010404 medicinal & biomolecular chemistrychemistryDrug Resistance NeoplasmAntileukemic activityDrug Screening Assays AntitumorSesquiterpene lactonesSesquiterpenesTwo-dimensional nuclear magnetic resonance spectroscopyDerivative (chemistry)Lactonemedicine.drugFitoterapia
researchProduct

Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study

2015

Globally, there is substantial concern regarding the challenges of treating complex drug resistance patterns in multidrug resistant tuberculosis cases. Utilising data from three different settings (Estonia, Latvia, Romania) we sought to contrast drug susceptibility profiles for multidrug resistant tuberculosis cases, highlight the difficulties in designing universal regimen, and inform future regimen selection. Demographic and microbiological surveillance data for multidrug resistant tuberculosis cases from 2004-13 were analysed. High levels of additional resistance to currently recommended second line drugs were seen in all settings, with extensive variability between countries. Accurate d…

COUNTRIESEstoniaMaleDrug Resistance Multiple Bacterial/drug effectsFluoroquinolones/pharmacologyGeneral Science & TechnologyAntitubercular Agents/therapeutic useRomania/epidemiologyAntitubercular Agentslcsh:MedicineDrug Resistance Multiple BacterialMD MultidisciplinaryTuberculosis Multidrug-ResistantHumansMULTIDRUG-RESISTANT TUBERCULOSISlcsh:ScienceLatvia/epidemiologyDemographyScience & TechnologyRomanialcsh:REstonia/epidemiologyLatviaMultidisciplinary SciencesCross-Sectional StudiesScience & Technology - Other Topicslcsh:QFemaleTuberculosis Multidrug-Resistant/drug therapyResearch ArticleFluoroquinolonesPLoS ONE
researchProduct

Monitoring changes in anti-tuberculosis treatment: associated factors determined at the time of diagnosis

2013

OBJECTIVES: To determine predictive factors for changes in standard anti-tuberculosis chemotherapy at the time of diagnosis. METHODS: A prospective study was performed among tuberculosis (TB) patients treated at specialised centres during 2008-2009. Treatment outcome was monitored per standard guidelines. Treatment was considered successful if the patient was cured or completed treatment. Factors associated with treatment modification were analysed at the bivariate and multivariate levels using logistic regression. RESULTS: A total of 427 patients were included in the study. The initial standard treatment regimen was retained for 249 patients (58.3%), extended to 9 months for 36 (8.4%) and …

AdultMalePulmonary and Respiratory MedicinePediatricsmedicine.medical_specialtyTime FactorsMultivariate analysisTuberculosisAntitubercular AgentsComorbiditySex FactorsDrug Resistance Multiple BacterialTuberculosis Multidrug-ResistantOdds RatioHumansTuberculosisMedicineProspective StudiesProspective cohort studyDrug Substitutionbusiness.industryStandard treatmentRemission InductionAge FactorsOdds ratioMiddle Agedmedicine.diseaseComorbidityRegimenLogistic ModelsTreatment OutcomeInfectious DiseasesSpainMultivariate AnalysisPractice Guidelines as TopicSputumDrug Therapy CombinationFemaleGuideline Adherencesense organsmedicine.symptombusinessThe International Journal of Tuberculosis and Lung Disease
researchProduct

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia

2016

This test decreased time to treatment initiation by 66%–84%.

0301 basic medicineOncologyMaleEpidemiologylcsh:Medicine0302 clinical medicine1108 Medical MicrobiologyTuberculosis Multidrug-Resistant030212 general & internal medicinebacteriaDecreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test Latviabiologytime to treatment initiationDrug Resistance MicrobialMiddle Agedmultidrug-resistant tuberculosisRifampin resistanceInfectious Diseases1117 Public Health And Health ServicesTuberculosis Multidrug-Resistant/diagnosisFemaleRifampinLife Sciences & BiomedicineMicrobiology (medical)Adultmedicine.medical_specialtyTuberculosisAdolescentpulmonary030106 microbiologyXpert MTB/RIFImmunologyTime to treatmentMicrobiologylcsh:Infectious and parasitic diseasesTime-to-TreatmentMycobacterium tuberculosismolecular diagnostics03 medical and health sciencesYoung AdultAntibiotic resistancemultidrug resistanceInternal medicinemedicineHumanslcsh:RC109-216Multivariable modelantimicrobial resistanceTuberculin testAntibiotics AntitubercularScience & Technologybusiness.industryTuberculin TestResearchlcsh:RMycobacterium tuberculosis/drug effects1103 Clinical SciencesMycobacterium tuberculosisbiology.organism_classificationmedicine.diseaseAntibiotics Antitubercular/pharmacologyLatviatuberculosis and other mycobacteriaMultiple drug resistanceMODELTuberculin Test/methodsbusinessRifampin/pharmacologyMDR TB
researchProduct

Quantifying transmission fitness costs of multi-drug resistant tuberculosis.

2021

As multi-drug resistant tuberculosis (MDR-TB) continues to spread, investigating the transmission potential of different drug-resistant strains becomes an ever more pressing topic in public health. While phylogenetic and transmission tree inferences provide valuable insight into possible transmission chains, phylodynamic inference combines evolutionary and epidemiological analyses to estimate the parameters of the underlying epidemiological processes, allowing us to describe the overall dynamics of disease spread in the population. In this study, we introduce an approach to Mycobacterium tuberculosis (M. tuberculosis) phylodynamic analysis employing an existing computationally efficient mod…

EpidemiologyComputer scienceAntibiotic resistance030231 tropical medicinePopulationAntitubercular AgentsInferenceInfectious and parasitic diseasesRC109-216Drug resistanceComputational biologyMicrobial Sensitivity TestsMicrobiologylaw.inventionMycobacterium tuberculosis03 medical and health sciencesMulti-type birth–death model0302 clinical medicinelawVirologyMulti-type birth-death modelTuberculosis Multidrug-ResistantmedicineHumans030212 general & internal medicineWhole genome M. tuberculosiseducationEpidemicsPhylogenyeducation.field_of_studybiologyPhylogenetic treeMulti-drug-resistant tuberculosisPublic Health Environmental and Occupational HealthAntibiotic resistance; Multi-type birth–death model; Phylodynamics; Whole genome M. tuberculosisMycobacterium tuberculosismedicine.diseasebiology.organism_classificationPhylodynamics614: Public Health und GesundheitsförderungInfectious DiseasesViral phylodynamicsTransmission (mechanics)ParasitologyEpidemics
researchProduct

Predicting resistant etiology in hospitalized patients with blood cultures positive for Gram-negative bacilli

2018

Abstract Objective To develop a risk-scoring tool to predict multidrug-resistant (MDR) etiology in patients with bloodstream infections (BSI) caused by Gram-negative bacilli (GNB). Methods A prospective multicenter study analyzed patients with BSI hospitalized in 31 Internal Medicine wards in Italy from March 2012 to December 2012. Patients with BSI caused by MDR-GNB (non-susceptible to at least one agent in three antimicrobial categories) were compared to those with BSI due to susceptible GNB. A logistic regression to identify predictive factors of MDR-GNB was performed and the odds ratio (OR) were calculated. A score to predict the risk of MDR was developed. Results Of 533 BSI episodes, 2…

Male0301 basic medicineMultivariate analysisGram-negative bacilliHospitalized patientsLogistic regressionLikelihood ratios in diagnostic testingRisk FactorsDrug Resistance Multiple BacterialMedicineAge FactorMultidrug-resistantProspective StudiesMultivariate AnalysiAged 80 and overAge FactorsAnti-Bacterial AgentsHospitalizationItalyBloodstream infections; Gram-negative bacilli; Multidrug-resistantBloodstream infections; Gram-negative bacilli; Multidrug-resistant; Internal MedicineFemaleSettore SECS-S/01 - StatisticaHumanmedicine.medical_specialtyLogistic Model030106 microbiologyBloodstream infection03 medical and health sciencesInternal medicineAnti-Bacterial AgentGram-Negative BacteriaGram-Negative Bacterial InfectionInternal MedicineHumansAgedbusiness.industryRisk FactorGram negative bacilliOdds ratiomedicine.diseaseProspective StudieLogistic ModelsROC CurveBlood CultureBacteremiaMultivariate AnalysisEtiologyBloodstream infectionsGram-Negative Bacterial Infectionsbusiness
researchProduct

Learning From Mistakes: The Role of Phages in Pandemics

2021

The misuse of antibiotics is leading to the emergence of multidrug-resistant (MDR) bacteria, and in the absence of available treatments, this has become a major global threat. In the middle of the recent severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic, which has challenged the whole world, the emergence of MDR bacteria is increasing due to prophylactic administration of antibiotics to intensive care unit patients to prevent secondary bacterial infections. This is just an example underscoring the need to seek alternative treatments against MDR bacteria. To this end, phage therapy has been proposed as a promising tool. However, further research in the field is mandatory to assure…

Microbiology (medical)medicine.medical_specialtyantibiotic resistancephage therapyPhage therapyPhage therapymedicine.drug_classMultidrug-resistant bacteriamedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibioticslcsh:QR1-502multidrug-resistant bacteriaEmergent pathogenMicrobiologylcsh:Microbiologylaw.inventionAntibiotic resistancelawPandemicmedicineIntensive care medicinePublic healthbusiness.industryTreatment regimenPublic healthpublic healthIntensive care unitemergent pathogenPerspectivebusinessFrontiers in Microbiology
researchProduct

Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission

2007

Background Multidrug-resistant gram-negative bacilli (MDRGN) are an important cause of nosocomial infections in neonatal intensive care units (NICUs). We conducted a 1-year prospective surveillance study in an NICU to assess the epidemiology of MDRGN among newborns and the relative importance of acquisition routes. Methods Neonates admitted at the NICU of the Dipartimento Materno-Infantile, University Hospital, Palermo, Italy, from January 7, 2003, to January 6, 2004, were included in the study. Colonization of patients with MDRGN was assessed by cultures of rectal swabs sampled twice a week. Pulsed-field gel electrophoresis was used to determine relatedness among MDRGN isolates. Extended-s…

Malemedicine.medical_specialtyPediatricsNeonatal intensive care unitEpidemiologymedicine.drug_classAntibioticsBreastfeedingMicrobial Sensitivity TestsEnterobacteriaceaeIntensive Care Units NeonatalIntensive careEpidemiologymedicineHumansProspective StudiesCross InfectionInfection ControlSurveillanceTransmission (medicine)business.industryHealth PolicyIncidence (epidemiology)Infant NewbornPublic Health Environmental and Occupational Healthneonatal intensive care unitDrug Resistance MultipleElectrophoresis Gel Pulsed-FieldInfectious DiseasesItalyFemaleGentamicinGram-Negative Bacterial InfectionsbusinessSentinel Surveillancemultidrug-resistant gram-negative bacillimedicine.drug
researchProduct

Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016

2018

In Italy, rifampicin-resistant and MDR-TB were high in foreign-born persons, but decreased from 2009 to 2016

0301 basic medicinePulmonary and Respiratory MedicineExtensively Drug-Resistant TuberculosisAntitubercular AgentsEmigrants and ImmigrantsAntitubercular Agents; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Humans; Italy; Mycobacterium tuberculosis; Rifampin; Tuberculosis Multidrug-ResistantMycobacterium tuberculosis03 medical and health sciences0302 clinical medicineTuberculosis Multidrug-Resistantpolycyclic compoundsmedicineTuberculosisHumansbiologybusiness.industryExtensively drug-resistant tuberculosisMycobacterium tuberculosisMultidrug-Resistantmedicine.diseasebiology.organism_classificationVirology030104 developmental biology030228 respiratory systemItalyRifampinbusinessRifampicinmedicine.drug
researchProduct

Implementation of A Year-Long Antimicrobial Stewardship Program in A 227-Bed Community Hospital in Southern Italy

2023

Background: Healthcare-Acquired Infections (HAIs) are serious healthcare complications affecting hospital stay, in-hospital mortality, and costs. Root cause analysis has identified the inappropriate use of antibiotics as the main causative factor in the expansion of multi-drug-resistant organisms (MDRO) in our hospital. An Antimicrobial Stewardship (AMS) program was implemented to optimize antibiotic use, limit the development of resistance, improve therapeutic efficacy and clinical outcomes, and reduce costs. Methods: The stewardship strategies were: antimicrobial oversight on “critical” antibiotics; the development of hospital guidelines on antibiotic selection with the production of a co…

healthcare-acquired infections (HAIs); multidrug-resistant organism (MDRO); antimicrobial stewardship (AMS); patient safety; medico-legal issues; responsibility; litigationantimicrobial stewardship (AMS)Health Toxicology and Mutagenesislitigationpatient safetyPublic Health Environmental and Occupational Healthmedico-legal issueresponsibility.healthcare-acquired infections (HAIs)multidrug-resistant organism (MDRO)International Journal of Environmental Research and Public Health
researchProduct